A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial

El-Deyarbi M, Ahmed L, King J, Adi ZS, Al Juboori A, Mansour NA, Al Nuaimi H, Beiram R, Aburuz S. Impact of multifactorial interventions with[...]

Estimation of the global prevalence and burden of insomnia: a systematic literature review-based analysis

Benjafield AV, Sert Kuniyoshi FH, Malhotra A, Martin JL, Morin CM, Maurer LF, Cistulli PA, Pépin JL, Wickwire EM; medXcloud group. Estimation of the global[...]

Hospital Patient Experience Worsened With the COVID-19 Pandemic, Especially for Older Adults, and Remains Worse than Before

Beckett MK, W Cohea C, Saliba D, Cleary PD, A Giordano L, Elliott MN. Hospital Patient Experience Worsened With the COVID-19 Pandemic, Especially for Older[...]